Molecular basis of human salt sensitivity: The role of the 11β-hydroxysteroid dehydrogenase type 2

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 10, 1999, Pages 3745-3749

  Lovati, Emanuela ^a   Ferrari, Paolo ^a   Dick, Bernhard ^a   Jostarndt, Kristin ^a   Frey, Brigitte M ^a   Frey, Felix J ^a   Schorr, Ulrike ^b   Sharma, Arya M ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; BIOCHEMICAL MARKER; CORTISONE; GLUCOCORTICOID; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR;

ADULT; ALLELE; ARTERIAL PRESSURE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INACTIVATION; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE URINE LEVEL; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SODIUM RETENTION;

EID: 0033305356     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.10.6098     Document Type: Article

References (31)

1. Localization of 11β-hydroxysteroid dehydrogenase tissue-specific protector of the mineralocorticoid receptor
2. Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated
3. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme
4. Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase
5. Point mutations abolish 11βhydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess
6. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11βhydroxysteroid dehydrogenase type 2
7. Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age
8. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol
9. The relation of arterial pressure with plasma and body electrolytes is similar in Conn's syndrome and essential hypertension
10. Deficient inactivation of cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension
11. Evidence of coexisting changes in 11β-hydroxysteroid dehydrogenase and 5β-reductase activity in subjects with untreated essential hypertension
12. Genetic association of flanking microsatellites with essential hypertension in blacks
13. Increased glucocorticoid activity in men with cardiovascular risk factors
14. Salt sensitivity. Definition, conception, methodology and long-term issues
15. Salt sensitivity of blood pressure in humans
16. Salt sensitivity as a phenotype for genetic studies of human hypertension
17. A new polymorphic restriction site in the human 11β-hydroxysteroid dehydrogenase gene
18. Structural analysis and evaluation of the 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) gene in human essential hypertension
19. Effects of sodium salts on pressor reactivity in salt-sensitive men
20. Relationship between ambulatory and resting blood pressure responses to dietary salt restriction in normotensive men
21. Reliability of saltsensitivity testing in normotensive subjects
22. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE
23. Profiling steroid hormones and urinary steroids
24. Role of atrial natriuretic factor in changes in the responsiveness of aldosterone to angiotensin II secondary to sodium loading and depletion in man
25. The syndrome of apparent mineralocorticoid excess: Its association with 11 βdehydrogenase and 5 βreductase deficiency and some consequences for corticosteroid metabolism
26. Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess
27. Urinary free cortisone and the assessment of 11β-hydroxysteroid dehydrogenase activity in man
28. Increased urinary free cortisol. A potential phenotype of essential hypertension
29. Impact of dietary Na+ on glycyrrhetinic acid-like factors (kidney 11β-(HSD2)-GALFs) in human essential hypertension
30. A genetic defect resulting in mild low-renin hypertension
31. The (political) science of salt